Literature DB >> 33479028

Translational Regulation of Cancer Metastasis.

Douglas S Micalizzi1,2, Richard Y Ebright1, Daniel A Haber3,2,4, Shyamala Maheswaran3,5.   

Abstract

Deregulation of the mRNA translational process has been observed during tumorigenesis. However, recent findings have shown that deregulation of translation also contributes specifically to cancer cell spread. During metastasis, cancer cells undergo changes in cellular state, permitting the acquisition of features necessary for cell survival, dissemination, and outgrowth. In addition, metastatic cells respond to external cues, allowing for their persistence under significant cellular and microenvironmental stresses. Recent work has revealed the importance of mRNA translation to these dynamic changes, including regulation of cell states through epithelial-to-mesenchymal transition and tumor dormancy and as a response to external stresses such as hypoxia and immune surveillance. In this review, we focus on examples of altered translation underlying these phenotypic changes and responses to external cues and explore how they contribute to metastatic progression. We also highlight the therapeutic opportunities presented by aberrant mRNA translation, suggesting novel ways to target metastatic tumor cells. ©2021 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33479028      PMCID: PMC7854484          DOI: 10.1158/0008-5472.CAN-20-2720

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   13.312


  84 in total

Review 1.  Translational control in cancer.

Authors:  Deborah Silvera; Silvia C Formenti; Robert J Schneider
Journal:  Nat Rev Cancer       Date:  2010-04       Impact factor: 60.716

2.  Translation of vascular endothelial growth factor mRNA by internal ribosome entry: implications for translation under hypoxia.

Authors:  I Stein; A Itin; P Einat; R Skaliter; Z Grossman; E Keshet
Journal:  Mol Cell Biol       Date:  1998-06       Impact factor: 4.272

Review 3.  VEGF in Signaling and Disease: Beyond Discovery and Development.

Authors:  Rajendra S Apte; Daniel S Chen; Napoleone Ferrara
Journal:  Cell       Date:  2019-03-07       Impact factor: 41.582

4.  mTORC1 and mTORC2 regulate EMT, motility, and metastasis of colorectal cancer via RhoA and Rac1 signaling pathways.

Authors:  Pat Gulhati; Kanika A Bowen; Jianyu Liu; Payton D Stevens; Piotr G Rychahou; Min Chen; Eun Y Lee; Heidi L Weiss; Kathleen L O'Connor; Tianyan Gao; B Mark Evers
Journal:  Cancer Res       Date:  2011-03-23       Impact factor: 12.701

Review 5.  Mechanisms of lymphatic metastasis.

Authors:  Sinem Karaman; Michael Detmar
Journal:  J Clin Invest       Date:  2014-03-03       Impact factor: 14.808

6.  An ATP-competitive mammalian target of rapamycin inhibitor reveals rapamycin-resistant functions of mTORC1.

Authors:  Carson C Thoreen; Seong A Kang; Jae Won Chang; Qingsong Liu; Jianming Zhang; Yi Gao; Laurie J Reichling; Taebo Sim; David M Sabatini; Nathanael S Gray
Journal:  J Biol Chem       Date:  2009-01-15       Impact factor: 5.157

7.  Epithelial-to-mesenchymal transition activates PERK-eIF2α and sensitizes cells to endoplasmic reticulum stress.

Authors:  Yu-Xiong Feng; Ethan S Sokol; Catherine A Del Vecchio; Sandhya Sanduja; Jasper H L Claessen; Theresa A Proia; Dexter X Jin; Ferenc Reinhardt; Hidde L Ploegh; Qiu Wang; Piyush B Gupta
Journal:  Cancer Discov       Date:  2014-04-04       Impact factor: 39.397

Review 8.  Targeting RNA helicases in cancer: The translation trap.

Authors:  Marise R Heerma van Voss; Paul J van Diest; Venu Raman
Journal:  Biochim Biophys Acta Rev Cancer       Date:  2017-09-28       Impact factor: 10.680

Review 9.  The integrated stress response.

Authors:  Karolina Pakos-Zebrucka; Izabela Koryga; Katarzyna Mnich; Mila Ljujic; Afshin Samali; Adrienne M Gorman
Journal:  EMBO Rep       Date:  2016-09-14       Impact factor: 8.807

10.  Circulating tumor cell clusters are oligoclonal precursors of breast cancer metastasis.

Authors:  Nicola Aceto; Aditya Bardia; David T Miyamoto; Maria C Donaldson; Ben S Wittner; Joel A Spencer; Min Yu; Adam Pely; Amanda Engstrom; Huili Zhu; Brian W Brannigan; Ravi Kapur; Shannon L Stott; Toshi Shioda; Sridhar Ramaswamy; David T Ting; Charles P Lin; Mehmet Toner; Daniel A Haber; Shyamala Maheswaran
Journal:  Cell       Date:  2014-08-28       Impact factor: 41.582

View more
  8 in total

Review 1.  CK2 and the Hallmarks of Cancer.

Authors:  May-Britt Firnau; Angela Brieger
Journal:  Biomedicines       Date:  2022-08-16

Review 2.  Ribosome Biogenesis: A Central Player in Cancer Metastasis and Therapeutic Resistance.

Authors:  Amr R Elhamamsy; Brandon J Metge; Heba A Alsheikh; Lalita A Shevde; Rajeev S Samant
Journal:  Cancer Res       Date:  2022-07-05       Impact factor: 13.312

Review 3.  Nano Drug Delivery System for Tumor Immunotherapy: Next-Generation Therapeutics.

Authors:  Lili Zhou; Manshu Zou; Yilin Xu; Peng Lin; Chang Lei; Xinhua Xia
Journal:  Front Oncol       Date:  2022-05-19       Impact factor: 5.738

4.  Inhibition of eEF2K synergizes with glutaminase inhibitors or 4EBP1 depletion to suppress growth of triple-negative breast cancer cells.

Authors:  YoungJun Ju; Yaacov Ben-David; Daniela Rotin; Eldad Zacksenhaus
Journal:  Sci Rep       Date:  2021-04-28       Impact factor: 4.379

5.  Prognosis and Dissection of Immunosuppressive Microenvironment in Breast Cancer Based on Fatty Acid Metabolism-Related Signature.

Authors:  Yuhui Tang; Wenwen Tian; Jindong Xie; Yutian Zou; Zehao Wang; Ning Li; Yan Zeng; Linyu Wu; Yue Zhang; Song Wu; Xiaoming Xie; Lu Yang
Journal:  Front Immunol       Date:  2022-03-31       Impact factor: 7.561

6.  SNAIL Induces EMT and Lung Metastasis of Tumours Secreting CXCL2 to Promote the Invasion of M2-Type Immunosuppressed Macrophages in Colorectal Cancer.

Authors:  Zhen Bao; Wei Zeng; Di Zhang; Liyong Wang; Xin Deng; Jianqin Lai; Jian Li; Jin Gong; Guoan Xiang
Journal:  Int J Biol Sci       Date:  2022-04-11       Impact factor: 10.750

Review 7.  Interplay of receptor-ligand binding and lipid domain formation during cell adhesion.

Authors:  Long Li; Jinglei Hu; Bartosz Różycki; Jing Ji; Fan Song
Journal:  Front Mol Biosci       Date:  2022-09-20

8.  Deficiency of eIF4B Increases Mouse Mortality and Impairs Antiviral Immunity.

Authors:  Biao Chen; Yuhai Chen; Kul Raj Rai; Xuefei Wang; Shasha Liu; Yingying Li; Meng Xiao; Yun Ma; Guoqing Wang; Guijie Guo; Shile Huang; Ji-Long Chen
Journal:  Front Immunol       Date:  2021-09-10       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.